This is to inform you that Outcome of the Board Meeting of the Company held on today i.e. Tuesday 5th May, 2026 in accordance with SEBl (Listing Obligations and Disclosures Requirements) Regulations, 2015, has been approved by the Board of Directors of the Company and taken on record inter-alia the following items; 1.) Consideration and Approval of Audited Financial Result for the Year ended 31st March, 2026. 2.) Independent Auditor’s Report in pursuance with Regulation 33 of SEBI (LODR) Regulations, 2015 for the F.Y. 31st March, 2026. Further, we hereby declare that the Auditor of the Company has issued the Audit report under the Companies Act, 2013 and financial results as prepared under SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015 for the financial year ended on March 31, 2026 with “Unmodified Opinion”. The board meeting commenced at 04.45 PM and concluded at 05:15 PM. We request you to kindly take on record the same. Thanking You.
Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that a meeting of the Board of Directors of the Company will be held on Tuesday 5th May 2026 inter alia, to consider following businesses: - 1.) Approve and take on record the Audited Standalone Financial Results of the Company for the quarter and year ended on 31st March 2026 along with the Reports of the Auditors thereon. 2.) Any other matter with the permission of the board which the Board may think fit. Please take the above intimation in your records. Thanking You.
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyAmerise Biosciences Ltd 2CIN NO.L29199GJ1984PLC007195 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. YES Name of the Company Secretary: SONI PANDIYA Designation: COMPANY SECRETARY EmailId: amraddeepindustries@gmail.com Name of the Chief Financial Officer: ALBERT HINES Designation: CFO EmailId: amraddepindustries@gmail.com Date: 22/04/2026 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.